Memphasys Targets Global Fertility Market as Clinical Trial Nears Completion
We’re excited to share that our Felix™ System is nearing the completion of its clinical trial in Australia, with 95% of…
Memphasys’ Innovative RoXsta™ System: Redefining Oxidative Stress Measurement
With the RoXsta™ system, Memphasys is positioned to lead the way in oxidative stress measurement and management,…
Looking Back: A Year of Growth and Progress at Memphasys
From launching our Felix™ System in new markets to expanding our partnerships globally, we’ve been laser-focused on our…
Advancements in Fertility Technology: Memphasys’ Cutting-Edge Solutions
As technologies such as cryopreservation continue to progress, we remain at the forefront, offering solutions designed…
Memphasys recruit Mike Cameron, to accelerate the development of animal fertility solutions.
Memphasys welcomes Mike Cameron to boost its animal fertility program, focusing on AI Port and MABS, improving…
Equine Fertility Breakthrough: Felix™ Device Positioned for Global Market Launch
We’re excited to announce that we’ve embarked on a three-year equine fertility study aimed at establishing our Felix™…
Memphasys Q&A: On a mission to fine tune animal fertility.
Optimised animal breeding success can only be a great thing for our community, which is why Memphasys is committed to…
The Growing Challenge of Male Infertility in India: New Solutions on the Horizon
Male infertility has emerged as a significant health issue in India, accounting for nearly 40-50% of all infertility…
Memphasys: Embracing a contemporary work environment and keeping costs in check with a new office move.
Memphasys office relocation and strategic management change to a more efficient space have significantly reduced costs.
Over $1M in Funding Secured to Accelerate Innovations in Reproductive Biotechnology
We are excited to announce significant financial developments that promise to propel our innovative projects forward.…